These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8908044)

  • 1. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children.
    Green M; Reyes J; Jabbour N; Yunis E; Putnam P; Todo S; Rowe D
    Transplant Proc; 1996 Oct; 28(5):2759-60. PubMed ID: 8908044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients.
    Rogers BB; Conlin C; Timmons CF; Dawson DB; Krisher K; Andrews WS
    Pediatr Pathol Lab Med; 1997; 17(3):391-400. PubMed ID: 9185219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant.
    Dellemijn PL; Brandenburg A; Niesters HG; van den Bent MJ; Rothbarth PH; Vlasveld LT
    Bone Marrow Transplant; 1995 Aug; 16(2):311-2. PubMed ID: 7581154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis by polymerase chain reaction of ocular posttransplant lymphoproliferative disorder after pediatric renal transplantation.
    Al-Attar L; Berrocal A; Warman R; Dubovy S; Paredes A; Chan CC; Davis J
    Am J Ophthalmol; 2004 Mar; 137(3):569-71. PubMed ID: 15013889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system.
    Volpi A
    Herpes; 2004 Jun; 11 Suppl 2():120A-127A. PubMed ID: 15319099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients.
    Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Gish R; Cox K; So S; Esquivel CO; Krams SM
    Transplant Proc; 1995 Feb; 27(1):1211-2. PubMed ID: 7533372
    [No Abstract]   [Full Text] [Related]  

  • 12. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L; Linde A; Falk KI
    Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
    Gómez E; Melón S; Fresno MF; Tricas L; Navascués R; de Oña M; Herreros M; Alvarez Grande J
    Nefrologia; 2002; 22(6):574-81. PubMed ID: 12516292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
    Weinstock DM; Ambrossi GG; Brennan C; Kiehn TE; Jakubowski A
    Bone Marrow Transplant; 2006 Mar; 37(6):539-46. PubMed ID: 16462755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in posttransplantation lymphoproliferative disease.
    Leruez-Ville M; Talbotec C; Iserin F; Salomon R; Lacaille F; Rouzioux C
    J Infect Dis; 2004 Oct; 190(8):1524-5; author reply 1525-6. PubMed ID: 15378447
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of in situ hybridization technique for quantitative assessment of ongoing symptomatic Epstein-Barr virus infection after living related liver transplantation.
    Egawa H; Ohishi T; Arai T; Inomata Y; Uemoto S; Asonuma K; Kinchi T; Okajima H; Matsui A; Kawashima N; Martinez OM; Tanaka K
    Clin Transplant; 1998 Apr; 12(2):116-22. PubMed ID: 9575399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
    Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
    Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR; Martinez OM; Krams SM; Cox K; So S; Esquivel CO
    Liver Transpl; 2000 Jan; 6(1):62-6. PubMed ID: 10648579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load.
    Hoshino Y; Kimura H; Kuzushima K; Tsurumi T; Nemoto K; Kikuta A; Nishiyama Y; Kojima S; Matsuyama T; Morishima T
    Bone Marrow Transplant; 2000 Jul; 26(2):199-201. PubMed ID: 10918431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.